BRIEF published on 05/07/2024 at 20:05, 1 year 2 months ago INSTALLUX S.A. annonce la mise à disposition de l'avis de convocation à l'AG Euronext Growth Paris Droits De Vote Assemblée Générale Informations Financières INSTALLUX S.A.
BRIEF published on 05/07/2024 at 20:05, 1 year 2 months ago INSTALLUX SA announces the availability of the notice of meeting for the AGM Euronext Growth Paris Voting Rights General Assembly INSTALLUX SA Financial Informations
BRIEF published on 05/07/2024 at 19:35, 1 year 2 months ago Assemblée Générale de JCDecaux SE : Approbation des Résolutions et Renouvellements de Mandats Assemblée Générale Gouvernance D'Entreprise Commissaires Aux Comptes Renouvellement De Mandat JCDecaux SE
BRIEF published on 05/07/2024 at 19:35, 1 year 2 months ago General Meeting of JCDecaux SE: Approval of Resolutions and Renewals of Mandates Corporate Governance General Assembly Auditors JCDecaux SE Renewal Of Mandate
BRIEF published on 05/07/2024 at 19:34, 1 year 2 months ago GenSight Biologics Announces Availability of Prospectus for New Shares Listing on Euronext Paris Euronext Paris Capital Increase Gene Therapy Prospectus GenSight Biologics
BRIEF published on 05/07/2024 at 19:34, 1 year 2 months ago GenSight Biologics annonce la mise à disposition d'un prospectus pour la cotation de nouvelles actions sur Euronext Paris Euronext Paris Augmentation De Capital Thérapie Génique Prospectus Produits Biologiques GenSight
BRIEF published on 05/07/2024 at 19:15, 1 year 2 months ago HiPay Group Announces Strong First Quarter Results for 2024 Revenue Growth Financial Outlook First Quarter 2024 Omnichannel Payments HiPay Group
BRIEF published on 05/07/2024 at 19:15, 1 year 2 months ago HiPay Group annonce de solides résultats pour le premier trimestre 2024 Hausse Des Revenus Perspectives Financières Premier Trimestre 2024 Paiements Omnicanaux Groupe HiPay
BRIEF published on 05/07/2024 at 19:15, 1 year 2 months ago Ajustement de la valeur nominale chez Pharnext Biopharmaceutique Réduction De Capital Valeur Nominale Pharnext Maladies Neurodégénératives
BRIEF published on 05/07/2024 at 19:15, 1 year 2 months ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
Published on 07/23/2025 at 17:30, 3 hours 42 minutes ago Plaintree Systems Inc. Announces Strategic Wind-Down of U.S. Subsidiary, Summit Aerospace USA Inc.
Published on 07/23/2025 at 15:20, 5 hours 52 minutes ago Forward Water Technologies Corp. Announces Preliminary Technology Evaluation Contract
Published on 07/23/2025 at 15:05, 6 hours 7 minutes ago Electric Metals and Lucid Pledge Strategic Collaboration to Promote Use of Domestic Critical Minerals Within Automotive Supply Chain
Published on 07/23/2025 at 15:00, 6 hours 12 minutes ago Vox Royalty Announces Major Expansion Approval at Binduli North Gold Project
Published on 07/23/2025 at 20:52, 19 minutes ago EQS-Adhoc: Dürr AG adjusts forecast for order intake; sales and earnings forecast confirmed
Published on 07/23/2025 at 19:59, 1 hour 12 minutes ago United Terra Enterprises PLC Announces Mandate for Senior Notes
Published on 07/23/2025 at 18:40, 2 hours 31 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/23/2025 at 18:09, 3 hours 2 minutes ago GFT Advances Strategy with Solid Preliminary H1, Bold AI Projects and Sector Expansion – 2025 Guidance Refined
Published on 07/23/2025 at 18:08, 3 hours 3 minutes ago EQS-Adhoc: GFT Technologies publishes preliminary half-year results and adjusts forecast for fiscal year 2025
Published on 07/23/2025 at 20:02, 1 hour 9 minutes ago Bilan semestriel du contrat de liquidité – Juin 2025
